» Articles » PMID: 10947855

Interaction of Dendritic Cells with Mycobacteria: Where the Action Starts

Overview
Publisher Wiley
Date 2000 Aug 18
PMID 10947855
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Dendritic cells (DC) are the major antigen-presenting cells in the induction of cellular responses to intracellular pathogens, such as mycobacteria. Recent studies have shown that they also play a critical role in the regulation of immune responses. The interaction of DC with microbial antigens may be the controlling factor in the development of a Th1-orientated protective immunity. Analysis of the innate response of DC to mycobacteria and the involvement of the DC receptors in antigen recognition have highlighted the pivotal role of these cells in T-cell activation. Mycobacteria-infected DC have an enhanced capacity to release pro-inflammatory cytokines and chemokines and are potent inducers of interferon-gamma-producing cells in vivo. Therefore, DC manipulation for maximal antigen presentation and Th1 cytokine production may form the basis of a new generation of vaccines, with improved efficacy against mycobacterial infections.

Citing Articles

From Bacterial Toxin to Therapeutic Agent: The Unexpected Fate of Mycolactone.

Ricci D, Demangel C Toxins (Basel). 2023; 15(6).

PMID: 37368670 PMC: 10303314. DOI: 10.3390/toxins15060369.


A Dendritic Cell-Activating Rv1876 Protein Elicits Mycobacterium Bovis BCG-Prime Effect via Th1-Immune Response.

Choi S, Choi H, Back Y, Park H, Lee K, Gurmessa S Biomolecules. 2021; 11(9).

PMID: 34572519 PMC: 8465531. DOI: 10.3390/biom11091306.


Evidence of a tolerogenic vaccine against AIDS in the Chinese macaque prefigures a potential human vaccine.

Andrieu J, Lu W Arch Virol. 2021; 166(5):1273-1282.

PMID: 33507389 PMC: 8036203. DOI: 10.1007/s00705-020-04935-6.


Mycobacterial glycolipid Di-O-acyl trehalose promotes a tolerogenic profile in dendritic cells.

Magallanes-Puebla A, Espinosa-Cueto P, Lopez-Marin L, Mancilla R PLoS One. 2018; 13(12):e0207202.

PMID: 30532264 PMC: 6287779. DOI: 10.1371/journal.pone.0207202.


A 30-year journey of trial and error towards a tolerogenic AIDS vaccine.

Andrieu J, Lu W Arch Virol. 2018; 163(8):2025-2031.

PMID: 30043201 PMC: 6096718. DOI: 10.1007/s00705-018-3936-1.